Finasteride and minoxidil operate through distinct biological pathways; finasteride acts as a 5-alpha-reductase inhibitor targeting androgen metabolism, whereas minoxidil serves as a non-androgen-targeted therapy.
The retrieved papers consistently confirm that finasteride is a 5-alpha-reductase inhibitor that suppresses dihydrotestosterone, while minoxidil acts through alternative, non-androgen-targeted pathways. Therefore, the claim that they utilize different mechanisms is fully supported.